Immutep Limited ADRIMM
Price$4.54Intrinsic value$1.6264% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $1.62median of 2 methodsbased on filings through 30 Jun 2025
Market Price $4.54Price as of 1 Oct 2026
Margin of Safety -64.4%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 20.3%/yr (balance of the path).17.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 619.6%Yr 719.0%Yr 818.3%Yr 917.7%Yr 1017.1%
20.3% → 17.1%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1115.6%Yr 1214.2%Yr 1312.8%Yr 1411.4%Yr 1510.0%Yr 168.6%Yr 177.2%Yr 185.8%Yr 194.4%Yr 203.0%
17.1% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 13.1%
Volatility vs market (adjusted beta)1.81

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetImmutep Limited ADRIMMHealth Care
Valuation
P/E—
P/S4.1×
P/B2.9×
EV / Revenue-2.0×
EV / EBITDA—
Profitability
Gross margin0.0%
Operating margin-981.4%
Net margin-594.6%
FCF margin-601.5%
Returns
ROE-42.7%
ROA-39.1%
ROIC—
Growth
Revenue growth (YoY)29.8%
5-yr fwd EPS growth17.1%
Financial strength
Debt / Equity0.02×
Current ratio11.69×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.